New drug trial seeks to control advanced cancers
NCT ID NCT07232420
Summary
This is an early-stage study testing a new drug called BL-M24D1 in patients with advanced non-small cell lung cancer and other solid tumors. The main goals are to find a safe dose, check how the body processes the drug, and look for early signs that it might help control the cancer. The study will enroll 33 adults whose cancer has spread and who have tried other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
Contact
Conditions
Explore the condition pages connected to this study.